HUP0203504A3 - Modified peptides and peptidomimetics for use in immunotherapy - Google Patents

Modified peptides and peptidomimetics for use in immunotherapy

Info

Publication number: HUP0203504A3
Authority: HU; Hungary
Prior art keywords: peptidomimetics; immunotherapy; modified peptides; peptides; modified
Prior art date: 1999-10-18

Application number

HU0203504A

Other languages

English (en)

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-18

Filing date

2000-10-12

Publication date

2005-03-29

2000-10-12 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2003-04-28 Publication of HUP0203504A2 publication Critical patent/HUP0203504A2/hu

2005-03-29 Publication of HUP0203504A3 publication Critical patent/HUP0203504A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Rehabilitation Therapy (AREA)
Hematology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HU0203504A 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy HUP0203504A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99203427		1999-10-18
PCT/EP2000/010230 WO2001029081A1 (en)	1999-10-18	2000-10-12	Modified peptides and peptidomimetics for use in immunotherapy

Publications (2)

Publication Number	Publication Date
HUP0203504A2 HUP0203504A2 (hu)	2003-04-28
HUP0203504A3 true HUP0203504A3 (en)	2005-03-29

Family

ID=8240756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0203504A HUP0203504A3 (en)	1999-10-18	2000-10-12	Modified peptides and peptidomimetics for use in immunotherapy

Country Status (23)

Country	Link
EP (1)	EP1226167A1 (hu)
JP (1)	JP2003512388A (hu)
KR (1)	KR20020047245A (hu)
CN (1)	CN1379786A (hu)
AR (1)	AR026068A1 (hu)
AU (1)	AU780238B2 (hu)
BR (1)	BR0014803A (hu)
CA (1)	CA2386398A1 (hu)
CO (1)	CO5271650A1 (hu)
CZ (1)	CZ20021356A3 (hu)
HK (1)	HK1046693A1 (hu)
HU (1)	HUP0203504A3 (hu)
IL (1)	IL148778A0 (hu)
MX (1)	MXPA02003520A (hu)
NO (1)	NO20021763D0 (hu)
NZ (1)	NZ518256A (hu)
PE (1)	PE20010692A1 (hu)
PL (1)	PL354590A1 (hu)
RU (1)	RU2002113107A (hu)
SK (1)	SK6842002A3 (hu)
TR (1)	TR200201036T2 (hu)
WO (1)	WO2001029081A1 (hu)
ZA (1)	ZA200202577B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002951212A0 (en) *	2002-09-04	2002-09-19	Monash University	A method of modulating cellular activity and molecules for use therein
WO2007117665A2 (en) *	2006-04-06	2007-10-18	Purdue Research Foundation	Derivatization-enhanced analysis of amino acids and peptides
US20100278745A1 (en) *	2006-12-21	2010-11-04	Norbert Lange	Compounds for fluorescence imaging
JP5346957B2 (ja)	2008-01-23	2013-11-20	ヘルレフホスピタル	不特定疾患の汎用マーカーとしてのｙｋｌ−４０
CA2737292A1 (en)	2008-09-15	2010-03-18	Herlev Hospital	Ykl-40 as a marker for gastrointestinal cancers
JP6798998B2 (ja) *	2014-11-07	2020-12-09	キネタ・クロニック・ペイン・リミテッド・ライアビリティ・カンパニーＫｉｎｅｔａＣｈｒｏｎｉｃＰａｉｎ，ＬＬＣ	コノトキシンペプチドの修飾および使用
EP3466963A1 (en) *	2017-10-05	2019-04-10	Suigeneris Farmacosmetics, S.L.	Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL115744A (en) *	1994-10-27	2000-07-16	Akzo Nobel Nv	Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) *	1996-04-24	1997-07-13	Akzo Nobel Nv	Peptides suitable for use in immunosuppressive therapy
EP0914333B1 (en) *	1996-06-07	2004-11-24	AstraZeneca AB	Peptide derivatives
IL122233A (en) *	1996-12-06	2001-04-30	Akzo Nobel Nv	Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

2000
- 2000-10-12 TR TR2002/01036T patent/TR200201036T2/xx unknown
- 2000-10-12 NZ NZ518256A patent/NZ518256A/en unknown
- 2000-10-12 HU HU0203504A patent/HUP0203504A3/hu unknown
- 2000-10-12 WO PCT/EP2000/010230 patent/WO2001029081A1/en not_active Application Discontinuation
- 2000-10-12 EP EP00972790A patent/EP1226167A1/en not_active Withdrawn
- 2000-10-12 CA CA002386398A patent/CA2386398A1/en not_active Abandoned
- 2000-10-12 IL IL14877800A patent/IL148778A0/xx unknown
- 2000-10-12 PL PL00354590A patent/PL354590A1/xx not_active Application Discontinuation
- 2000-10-12 CN CN00814418A patent/CN1379786A/zh active Pending
- 2000-10-12 CZ CZ20021356A patent/CZ20021356A3/cs unknown
- 2000-10-12 SK SK684-2002A patent/SK6842002A3/sk not_active Application Discontinuation
- 2000-10-12 AU AU11396/01A patent/AU780238B2/en not_active Ceased
- 2000-10-12 BR BR0014803-2A patent/BR0014803A/pt not_active IP Right Cessation
- 2000-10-12 RU RU2002113107/15A patent/RU2002113107A/ru not_active Application Discontinuation
- 2000-10-12 HK HK02108208.9A patent/HK1046693A1/zh unknown
- 2000-10-12 MX MXPA02003520A patent/MXPA02003520A/es unknown
- 2000-10-12 KR KR1020027004940A patent/KR20020047245A/ko not_active Withdrawn
- 2000-10-12 JP JP2001531879A patent/JP2003512388A/ja not_active Withdrawn
- 2000-10-17 PE PE2000001107A patent/PE20010692A1/es not_active Application Discontinuation
- 2000-10-18 CO CO00079334A patent/CO5271650A1/es not_active Application Discontinuation
- 2000-10-18 AR ARP000105458A patent/AR026068A1/es unknown
2002
- 2002-04-02 ZA ZA200202577A patent/ZA200202577B/en unknown
- 2002-04-15 NO NO20021763A patent/NO20021763D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL148778A0 (en)	2002-09-12
SK6842002A3 (en)	2002-09-10
AU1139601A (en)	2001-04-30
AR026068A1 (es)	2002-12-26
WO2001029081A1 (en)	2001-04-26
AU780238B2 (en)	2005-03-10
TR200201036T2 (tr)	2002-08-21
HUP0203504A2 (hu)	2003-04-28
HK1046693A1 (zh)	2003-01-24
JP2003512388A (ja)	2003-04-02
CN1379786A (zh)	2002-11-13
RU2002113107A (ru)	2004-01-10
EP1226167A1 (en)	2002-07-31
BR0014803A (pt)	2002-06-11
NZ518256A (en)	2004-01-30
MXPA02003520A (es)	2002-08-20
NO20021763L (no)	2002-04-15
PL354590A1 (en)	2004-01-26
CA2386398A1 (en)	2001-04-26
CZ20021356A3 (cs)	2002-07-17
NO20021763D0 (no)	2002-04-15
ZA200202577B (en)	2003-09-23
CO5271650A1 (es)	2003-04-30
PE20010692A1 (es)	2001-07-06
KR20020047245A (ko)	2002-06-21

Publication	Publication Date	Title
HUP0102900A3 (en)	2002-02-28	Improved solid-phase peptide synthesis and agent for use in such synthesis
HUP0002789A3 (en)	2003-08-28	Integrin binding peptide and use thereof
HUP0102535A3 (en)	2005-12-28	Cd19xcd3 specific polypeptides and uses thereof
HUP0000427A3 (en)	2001-09-28	Benzamidoaldehydes and their use as cysteine protease inhibitors
ZA9710646B (en)	1998-09-15	Aminoguanidines and alkoxyguanidines as protease inhibitors
IL145850A0 (en)	2002-07-25	Adhesion modulatory peptides and methods for use
GB9806806D0 (en)	1998-05-27	Peptides and uses thereof
HUP0105284A3 (en)	2003-12-29	Inhibitors for use in hemostasis and immune function
GB9700958D0 (en)	1997-03-05	Peptides for use in wound treatment
IL131707A0 (en)	2001-03-19	Acetylcholinesterase-derived peptides and uses thereof
HUP0203504A3 (en)	2005-03-29	Modified peptides and peptidomimetics for use in immunotherapy
GB9918155D0 (en)	1999-10-06	Proteins and peptides
GB0026134D0 (en)	2000-12-13	Peptides and their use
IL147345A0 (en)	2002-08-14	Drosphila recombination- associated protein and methods for use
HUP0201660A2 (en)	2002-08-28	Novel polypeptide and dna thereof
PL345958A1 (en)	2002-01-14	Novel peptides for use in immunotherapy of autoimmune diseases
EP1080185A4 (en)	2005-01-26	BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
GB9917165D0 (en)	1999-09-22	Polypeptides polynuclcotides and uses thereof
IL145233A0 (en)	2002-06-30	Recombinant plant proteins and methods utilizing the same
IL145527A0 (en)	2002-06-30	Retro-inverso prosaposin-derived peptides and use thereof
EP1302477A4 (en)	2005-06-01	PEPTIDE FRUCTOSE AND COMPLEX THEREOF ASSOCIATED WITH BINDING PROTEIN
AU3350097A (en)	1998-01-21	Immunocontraceptive methods and peptide or polypeptides for use in these methods
IL145152A0 (en)	2002-06-30	Novel protein and its use
EP1227149A4 (en)	2004-03-31	New protein and its use
GB0026135D0 (en)	2000-12-13	Peptides and their use